South Korean medical device companies are demonstrating continued strength in the global market, securing significant contracts and driving innovation in healthcare technology. Several firms recently showcased their advancements at KIMES 2026, a major industry event.
Gangwon Medical Devices reportedly achieved 22.3 billion Korean won (approximately $16.3 million USD) in contracts at KIMES 2026, signaling sustained performance, according to reports.
The “Medical Korea 2026” forum is set to focus on the future of global healthcare, particularly the role of artificial intelligence. The event will serve as a platform for discussing advancements and collaborations in the field, according to a 대한민국 정책브리핑 report.
Huino is accelerating its entry into the wearable electrocardiogram market with its “MemoPatch M,” which incorporates technology designed to protect against defibrillation. This innovation aims to enhance the safety and reliability of wearable heart monitoring devices, as detailed in a 팜이데일리 article.
Newpong presented a vision for expanding the application of its ultrasound medical technology to consumer devices at KIMES 2026, outlining a structure for broader accessibility and use. This move could potentially disrupt the traditional medical imaging landscape, according to v.daum.net.
On the international front, the EU Business Hub is working to strengthen cooperation in healthcare and medical devices between Europe and South Korea. This initiative aims to foster collaboration and facilitate market access for companies in both regions, as reported by 한겨레. This development underscores the growing importance of international partnerships in the medical technology sector.
